Condition: Metastatic Uveal Melanoma · Metastatic Uveal Melanoma in the Liver · Sponsor: University of Miami
The purpose of this study is to determine the effects (good and bad) that Tebentafusp in combination with Yttrium-90 (Y-90) radioembolization has on patients with metastatic uveal melanoma that has spread to the liver.
This description comes directly from the study's public registry record.
Lynn Feun, MD · (305) 243-4981 · lfeun@med.miami.edu
Benjamin Spieler, MD · (305) 243-4229 · bspieler@med.miami.edu
Always discuss trial participation with your own doctor first.
| University of Miami | Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06627244